Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
Boston ScientificBSX |
-$1.82B |
 |
MedtronicMDT |
-$74M |
 |
Edwards LifesciencesEW |
-$534M |
 |
Intuitive SurgicalISRG |
-$1.27B |
 |
ConmedCNMD |
-$680,000 |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Bazaar Alan Lee | May 12, 2025 | Buy | 2,000 | $12.586 | $25,000 |
| Calafiore Massimo | May 9, 2025 | Buy | 10,000 | $12.54 | $130,000 |
| Bazaar Alan Lee | May 9, 2025 | Buy | 1,990 | $12.623 | $25,000 |
| Engine Capital Management, LP | May 7, 2025 | Buy | 83,375 | $12.31 | $1M |
| ENGINE CAPITAL, L.P. | May 7, 2025 | Buy | 83,375 | $12.31 | $1M |
| Engine Capital Management, LP | May 7, 2025 | Buy | 8,519 | $12.31 | $100,000 |
| Engine Capital Management, LP | May 7, 2025 | Buy | 8,106 | $12.31 | $100,000 |
| ENGINE CAPITAL, L.P. | May 7, 2025 | Buy | 8,519 | $12.31 | $100,000 |
| ENGINE CAPITAL, L.P. | May 7, 2025 | Buy | 8,106 | $12.31 | $100,000 |
| Cedron Jorge Andres | Apr 16, 2025 | Sell | 3,816 | $13.31 | $51,000 |
| Gillespie Geoffrey C | Apr 2, 2025 | Sell | 76 | $15.74 | $1,200 |
| Vitale Lucas | Mar 18, 2025 | Sell | 4,287 | $16.6 | $71,000 |
| Gillespie Geoffrey C | Mar 18, 2025 | Sell | 296 | $16.6 | $4,900 |
| Calafiore Massimo | Mar 5, 2025 | Buy | 9,914 | $17.43 | $170,000 |
| Gillespie Geoffrey C | Feb 4, 2025 | Sell | 187 | $18.08 | $3,400 |
| Gillespie Geoffrey C | Feb 3, 2025 | Sell | 767 | $17.79 | $14,000 |
| Andrews Julie | Jan 16, 2025 | Sell | 4,655 | $17.89 | $83,000 |
| Calafiore Massimo | Jan 13, 2025 | Sell | 9,203 | $17.1419 | $160,000 |
| Gillespie Geoffrey C | Jan 13, 2025 | Sell | 227 | $17.1419 | $3,900 |
| Calafiore Massimo | Jan 10, 2025 | Sell | 10,078 | $16.8306 | $170,000 |
| Gillespie Geoffrey C | Jan 10, 2025 | Sell | 248 | $16.8306 | $4,200 |
| Gillespie Geoffrey C | Jan 8, 2025 | Sell | 238 | $16.9718 | $4,000 |
| Gillespie Geoffrey C | Dec 17, 2024 | Sell | 26 | $17.84 | $460 |
| Hinrichs James F. | Sep 14, 2023 | Buy | 7,500 | $13.47 | $100,000 |
What's the latest insider transaction for Orthofix Medical?
The most recent insider transaction for Orthofix Medical was conducted by Bazaar Alan Lee, who sold 2,000 shares on May 12, 2025 at a price of $12.59 per share.
Which insider bought the most OFIX stock over the last two years?
ENGINE CAPITAL, L.P. has bought the most OFIX stock in the last 2 years, with a total value of $1.2M.
Which insider has sold the most OFIX stock over the last two years?
Calafiore Massimo has sold the most OFIX stock in the last 2 years, with a total value of $330,000.
What is the total value of insider transactions for Orthofix Medical (OFIX) in the last 2 years?
According to our estimates, the total value of insider transactions for Orthofix Medical in the last 2 years is positive, amounting to $2.3M. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
How do insider transactions over the last 2 years reflect on Orthofix Medical's market confidence?
Over the last 2 years, insider transactions for Orthofix Medical have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
